Ulla Elofsson, PhD, Associate Professor & Senior Scientist, Health and Life Science, Chemical Process and Pharmaceutical Development, RISE Research Institutes of Sweden AB
Synchrotron techniques are increasingly applied in pharmaceutical development. The synchrotron source MAX IV offers new possibilities by means of faster measurements and high brilliance. CoSAXS beamline is designed for studying formulation effects on protein solution structure and interactions using automated sample handling and data analysis. Examples on how synchrotron small angle X-ray techniques can be used, and suggestions on how the new developments at CoSAXS can contribute will be presented.